Core Viewpoint - Ruili Medical (02135) has entered into a subscription agreement to acquire shares in Laili Medical Limited, which will enhance its business operations in Hong Kong and provide potential investment returns [1][2] Group 1: Subscription Agreement Details - The agreement involves the issuance of a total of 170,000 shares to the first investor, Ruili Aesthetics Limited, for a subscription price of HKD 2.55 million, and 63,300 shares to the second investor, Bif Limited, for HKD 0.95 million [1] - After the completion of the agreement, Ruili Aesthetics Limited will hold 30.0%, Bif Limited will hold 19.0%, and the target company will be an indirect non-wholly owned subsidiary of Ruili Medical [1] Group 2: Business Strategy and Expectations - The board believes that the subscription aligns with the group's business expansion strategy and presents a unique opportunity to promote the brand and provide beauty services in Hong Kong [2] - The operational and financial performance of the target company is expected to improve after launching beauty services in Hong Kong, potentially leading to investment returns for the group [2]
瑞丽医美附属拟255万港元认购莱丽医美51.0%股权